Hereditary Angioedema Drug Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Hereditary Angioedema Drug Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI17491 | Date : Jan, 2021 | Pages :
186 | Region : Global |
Publisher : RI
The Hereditary Angioedema Drug market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Hereditary Angioedema Drug market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Competitive Landscape and Hereditary Angioedema Drug Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pharming Group NV
Shire plc
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Hereditary Angioedema Drug competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Hereditary Angioedema Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hereditary Angioedema Drug sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hereditary Angioedema Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hereditary Angioedema Drug markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hereditary Angioedema Drug market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Hereditary Angioedema Drug market for the forecast period 2020 - 2028?
• What are the driving forces in the Hereditary Angioedema Drug market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Hereditary Angioedema Drug industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Study Coverage
1.1 Hereditary Angioedema Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Product
1.4.2 C1 Esterase Inhibitor
1.4.3 Kallikrein Inhibitor
1.4.4 Selective Bradykinin B2 Receptor Antagonist
1.5 Market by End User
1.5.1 Global Hereditary Angioedema Drug Market Size Growth Rate by End User
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hereditary Angioedema Drug Market Size
2.1.1 Global Hereditary Angioedema Drug Revenue 2015-2028
2.1.2 Global Hereditary Angioedema Drug Sales 2015-2028
2.2 Hereditary Angioedema Drug Growth Rate by Regions
2.2.1 Global Hereditary Angioedema Drug Sales by Regions
2.2.2 Global Hereditary Angioedema Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Hereditary Angioedema Drug Sales by Manufacturers
3.1.1 Hereditary Angioedema Drug Sales by Manufacturers
3.1.2 Hereditary Angioedema Drug Sales Market Share by Manufacturers
3.1.3 Global Hereditary Angioedema Drug Market Concentration Ratio (CR5 and HHI)
3.2 Hereditary Angioedema Drug Revenue by Manufacturers
3.2.1 Hereditary Angioedema Drug Revenue by Manufacturers (2015-2020)
3.2.2 Hereditary Angioedema Drug Revenue Share by Manufacturers (2015-2020)
3.3 Hereditary Angioedema Drug Price by Manufacturers
3.4 Hereditary Angioedema Drug Manufacturing Base Distribution, Product Types
3.4.1 Hereditary Angioedema Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hereditary Angioedema Drug Product Type
3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Hereditary Angioedema Drug Sales by Product
4.2 Global Hereditary Angioedema Drug Revenue by Product
4.3 Hereditary Angioedema Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Hereditary Angioedema Drug Breakdown Data by End User
6 North America
6.1 North America Hereditary Angioedema Drug by Countries
6.1.1 North America Hereditary Angioedema Drug Sales by Countries
6.1.2 North America Hereditary Angioedema Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hereditary Angioedema Drug by Product
6.3 North America Hereditary Angioedema Drug by End User
7 Europe
7.1 Europe Hereditary Angioedema Drug by Countries
7.1.1 Europe Hereditary Angioedema Drug Sales by Countries
7.1.2 Europe Hereditary Angioedema Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hereditary Angioedema Drug by Product
7.3 Europe Hereditary Angioedema Drug by End User
8 Asia Pacific
8.1 Asia Pacific Hereditary Angioedema Drug by Countries
8.1.1 Asia Pacific Hereditary Angioedema Drug Sales by Countries
8.1.2 Asia Pacific Hereditary Angioedema Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hereditary Angioedema Drug by Product
8.3 Asia Pacific Hereditary Angioedema Drug by End User
9 Central & South America
9.1 Central & South America Hereditary Angioedema Drug by Countries
9.1.1 Central & South America Hereditary Angioedema Drug Sales by Countries
9.1.2 Central & South America Hereditary Angioedema Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hereditary Angioedema Drug by Product
9.3 Central & South America Hereditary Angioedema Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Hereditary Angioedema Drug by Countries
10.1.1 Middle East and Africa Hereditary Angioedema Drug Sales by Countries
10.1.2 Middle East and Africa Hereditary Angioedema Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hereditary Angioedema Drug by Product
10.3 Middle East and Africa Hereditary Angioedema Drug by End User
11 Company Profiles
11.1 Pharming Group NV
11.1.1 Pharming Group NV Company Details
11.1.2 Company Business Overview
11.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered
11.1.5 Pharming Group NV Recent Development
11.2 Shire plc
11.2.1 Shire plc Company Details
11.2.2 Company Business Overview
11.2.3 Shire plc Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shire plc Hereditary Angioedema Drug Products Offered
11.2.5 Shire plc Recent Development
11.3 CSL Limited
11.3.1 CSL Limited Company Details
11.3.2 Company Business Overview
11.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Limited Hereditary Angioedema Drug Products Offered
11.3.5 CSL Limited Recent Development
11.4 IBio Inc.
11.4.1 IBio Inc. Company Details
11.4.2 Company Business Overview
11.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2015-2020)
11.4.4 IBio Inc. Hereditary Angioedema Drug Products Offered
11.4.5 IBio Inc. Recent Development
11.5 BioCryst Pharmaceuticals, Inc.
11.5.1 BioCryst Pharmaceuticals, Inc. Company Details
11.5.2 Company Business Overview
11.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
11.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
11.6 Ionis Pharmaceuticals, Inc.
11.6.1 Ionis Pharmaceuticals, Inc. Company Details
11.6.2 Company Business Overview
11.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
11.6.5 Ionis Pharmaceuticals, Inc. Recent Development
12 Future Forecast
12.1 Hereditary Angioedema Drug Market Forecast by Regions
12.1.1 Global Hereditary Angioedema Drug Sales Forecast by Regions 2021-2028
12.1.2 Global Hereditary Angioedema Drug Revenue Forecast by Regions 2021-2028
12.2 Hereditary Angioedema Drug Market Forecast by Product
12.2.1 Global Hereditary Angioedema Drug Sales Forecast by Product 2021-2028
12.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Product 2021-2028
12.3 Hereditary Angioedema Drug Market Forecast by End User
12.4 North America Hereditary Angioedema Drug Forecast
12.5 Europe Hereditary Angioedema Drug Forecast
12.6 Asia Pacific Hereditary Angioedema Drug Forecast
12.7 Central & South America Hereditary Angioedema Drug Forecast
12.8 Middle East and Africa Hereditary Angioedema Drug Forecast
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hereditary Angioedema Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.